Clinical trial
Real-world Data From a Multi-center Study: Insights to the Effectiveness and Safety in Patients With Ovarian Cancer Receiving Niraparib as First-line Maintenance Therapy
NCT05734911 is registered in ClinicalTrials.gov with Zhongda Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Real-world Data From a Multi-center Study: Insights to the Effectiveness and Safety in Patients With Ovarian Cancer Receiving Niraparib as First-line Maintenance Therapy
- Lead sponsor
- Zhongda Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- January 1, 2019
- Completion date
- February 7, 2023
- Enrollment
- 199 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.